US Patent Issued to Evive Biotechnology (Shanghai) on Jan. 20 for "Methods for treating graft versus host disease" (Chinese Inventors)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,527,875, issued on Jan. 20, was assigned to Evive Biotechnology (Shanghai) Ltd (Shanghai).

"Methods for treating graft versus host disease" was invented by William Daley (Shanghai) and Xiaoqiang Yan (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are methods for treating graft versus host disease (GvHD) by administering a composition an agent comprising an IL-22 (such as an IL-22 dimer), and optionally an immunosuppressive therapy. The treatment can be administered for multiple cycles which are separated by a rest period and/or individuals who have a specific Ann Arbor score or a characterized gut microbiota profile. Also provided are ...